Squar Milner Financial Services
AVXL icon

Squar Milner Financial Services’s Anavex Life Sciences AVXL Stock Holding History

Squar Milner Financial Services’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-130,000
Closed -$640K – 17
2020
Q2 		$640K Hold
130,000
– – 0.36% 75
2020
Q1 		$409K Hold
130,000
– – 0.25% 88
2019
Q4 		$336K Hold
130,000
– – 0.17% 128
2019
Q3 		$592K Buy
+130,000
New +$375K 0.3% 88

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Squar Milner Financial Services's AVXL Position: Q3 2020 in Review

Squar Milner Financial Services sold out of Anavex Life Sciences (AVXL) in Q3 2020, closing a stake of 130,000 shares — an estimated $640K sold.

Squar Milner Financial Services first reported a position in AVXL in Q3 2019 and held it in 4 quarters. The position peaked at $640K in Q2 2020. 78 funds tracked by Wall St. Rank hold AVXL as of Q3 2020.

  • Squar Milner Financial Services reported no remaining Anavex Life Sciences position as of Q3 2020 after selling out during the quarter.
  • Squar Milner Financial Services sold 130,000 Anavex Life Sciences shares in Q3 2020, an estimated $640K.
  • Squar Milner Financial Services first reported a position in Anavex Life Sciences in Q3 2019 and held it in 4 quarters.
  • Squar Milner Financial Services's Anavex Life Sciences position peaked at $640K in Q2 2020.
  • 78 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2020.

Based on Squar Milner Financial Services's 13F filing for Q3 2020.